Written by: Ricardo Zwirtes, MD Vice President of Clinical Development, SQZ Biotechnologies As we continue to search for more effective treatments for head and neck cancers, cell therapy is an exciting field within immunotherapy that offers significant promise. Though there is broad...
Written by Dan P. Zandberg, MD Squamous cell carcinoma is the most common cancer that originates in the head and neck. The most frequent primary sites of origin in the United States are oral cavity, oropharynx, larynx, and hypopharynx. While the...
Written by Wey-Wey Kwok, JD The Center for Medicare Advocacy (CMA) is a non-profit, public interest law organization headquartered in Connecticut and Washington, D.C., that works to advance access to comprehensive Medicare coverage, health equity, and quality health care for older...
Written by Ron J. Karni, MD Head and neck cancer patients are experiencing increasing rates of survivorship. This also means many patients are living with the side effects of head and neck cancer treatment. Common side effects I hear from patients...
Written by Marshall Posner, MD & Eric Genden, MD, MHCA, FACS A large shift in the causes and natural history of head and neck cancer has radically changed the prognosis and survival of a significant fraction of patients in the last...
